Nisa Investment Advisors, LLC Intra Cellular Therapies, Inc. Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,676 shares of ITCI stock, worth $227,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,676
Previous 4,168 35.8%
Holding current value
$227,433
Previous $285,000 31.58%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$67.99 - $80.84 $101,441 - $120,613
-1,492 Reduced 35.8%
2,676 $195,000
Q2 2024

Jul 19, 2024
SELL
$64.76 - $79.84 $8,872 - $10,938
-137 Reduced 3.18%
4,168 $285,000
Q1 2024

May 01, 2024
BUY
$64.37 - $75.65 $4,699 - $5,522
73 Added 1.72%
4,305 $297,000
Q4 2023

Jan 25, 2024
SELL
$46.37 - $73.65 $8,810 - $13,993
-190 Reduced 4.3%
4,232 $303,000
Q3 2023

Nov 02, 2023
SELL
$52.09 - $64.1 $791,768 - $974,319
-15,200 Reduced 77.46%
4,422 $230,000
Q2 2023

Aug 11, 2023
BUY
$54.67 - $66.44 $829,890 - $1.01 Million
15,180 Added 341.74%
19,622 $1.24 Million
Q1 2023

May 02, 2023
SELL
$43.8 - $56.99 $876 - $1,139
-20 Reduced 0.45%
4,442 $241,000
Q3 2022

Nov 07, 2022
BUY
$42.7 - $59.99 $15,841 - $22,256
371 Added 9.07%
4,462 $205,000
Q2 2022

Aug 03, 2022
SELL
$43.0 - $65.64 $22,360 - $34,132
-520 Reduced 11.28%
4,091 $234,000
Q1 2022

Apr 29, 2022
SELL
$38.74 - $62.09 $164,954 - $264,379
-4,258 Reduced 48.01%
4,611 $282,000
Q4 2021

Feb 03, 2022
BUY
$35.2 - $53.42 $1,654 - $2,510
47 Added 0.53%
8,869 $421,000
Q3 2021

Oct 18, 2021
BUY
$28.72 - $42.49 $3,503 - $5,183
122 Added 1.4%
8,822 $329,000
Q4 2020

Jan 25, 2021
BUY
$23.34 - $32.22 $28,591 - $39,469
1,225 Added 16.39%
8,700 $277,000
Q3 2020

Oct 20, 2020
SELL
$17.61 - $31.86 $50,135 - $90,705
-2,847 Reduced 27.58%
7,475 $192,000
Q2 2020

Jul 27, 2020
BUY
$14.35 - $26.64 $6,773 - $12,574
472 Added 4.79%
10,322 $265,000
Q1 2020

Apr 17, 2020
BUY
$12.31 - $33.12 $5,785 - $15,566
470 Added 5.01%
9,850 $151,000
Q3 2019

Oct 17, 2019
BUY
$7.47 - $14.03 $70,068 - $131,601
9,380 New
9,380 $70,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.02B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email